Jpmorgan Chase & CO Mannkind Corp Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MNKD
# of Institutions
228Shares Held
133MCall Options Held
1.43MPut Options Held
849K-
Black Rock Inc. New York, NY22.6MShares$160 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$109 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY10.1MShares$71.5 Million5.97% of portfolio
-
State Street Corp Boston, MA9.56MShares$67.8 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.76MShares$62.1 Million0.62% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.82B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...